These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25771391)

  • 1. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease.
    Dong S; Bout-Tabaku S; Texter K; Jaggi P
    J Pediatr; 2015 May; 166(5):1283-8. PubMed ID: 25771391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review.
    Kumar S; Vaidyanathan B; Gayathri S; Rajam L
    Rheumatol Int; 2013 Apr; 33(4):1065-9. PubMed ID: 21132551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease.
    Keskindemirci G; Aktay Ayaz N; Melikoğlu N; Bornaun H; Aydoğmuş Ç; Aldemir E; Aydoğan G
    Turk J Pediatr; 2015; 57(5):518-21. PubMed ID: 27411422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
    Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
    Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
    World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.
    Binstadt BA; Levine JC; Nigrovic PA; Gauvreau K; Dedeoglu F; Fuhlbrigge RC; Weindling SN; Newburger JW; Sundel RP
    Pediatrics; 2005 Jul; 116(1):e89-93. PubMed ID: 15930186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Minoia F; Davì S; Horne A; Bovis F; Demirkaya E; Akikusa J; Ayaz NA; Al-Mayouf SM; Barone P; Bica B; Bolt I; Breda L; De Cunto C; Enciso S; Gallizzi R; Griffin T; Hennon T; Horneff G; Jeng M; Kapovic AM; Lipton JM; Magni Manzoni S; Rumba-Rozenfelde I; Magalhaes CS; Sewairi WM; Stine KC; Vougiouka O; Weaver LK; Davidsone Z; De Inocencio J; Ioseliani M; Lattanzi B; Tezer H; Buoncompagni A; Picco P; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    J Rheumatol; 2015 Jun; 42(6):994-1001. PubMed ID: 25877504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial manifestations and clinical course of systemic onset juvenile idiopathic arthritis: a ten-year retrospective study.
    Tsai HY; Lee JH; Yu HH; Wang LC; Yang YH; Chiang BL
    J Formos Med Assoc; 2012 Oct; 111(10):542-9. PubMed ID: 23089689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome in the acute phase of Kawasaki disease.
    Latino GA; Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):527-31. PubMed ID: 20485197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review.
    Jiang H; Yang Z
    Front Pediatr; 2020; 8():93. PubMed ID: 32211357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis.
    Lefèvre-Utile A; Galeotti C; Koné-Paut I
    Joint Bone Spine; 2014 May; 81(3):257-9. PubMed ID: 24793086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
    Singh S; Chandrakasan S; Ahluwalia J; Suri D; Rawat A; Ahmed N; Das R; Sachdeva MU; Varma N
    Rheumatol Int; 2012 Apr; 32(4):881-6. PubMed ID: 21221591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.
    Liquidano-Perez E; Maza-Ramos G; Salazar-Bailón JL; Yamazaki-Nakashimada MA; Rivas-Larrauri F
    Rheumatol Int; 2023 Jan; 43(1):183-189. PubMed ID: 36264324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
    BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study.
    Lukjanoviča K; Šlēziņa I; Dāvidsone Z; Šantere R; Budarina K; Staņēviča V
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.